Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug 16;14(8):e28052.
doi: 10.7759/cureus.28052. eCollection 2022 Aug.

Nonalcoholic Fatty Liver Disease and Hypothyroidism: What You Need to Know

Affiliations
Review

Nonalcoholic Fatty Liver Disease and Hypothyroidism: What You Need to Know

Viktoriya Bikeyeva et al. Cureus. .

Abstract

Non-alcoholic fatty liver disease (NAFLD) represents one of the leading causes of chronic liver disease globally, perhaps because of the drastic increase in prevalence around the world during the last 20 years and continues growing. The disease starts from simple steatosis (NAFL) that can progress to non-alcoholic steatohepatitis (NASH) and, in some patients, progress to cirrhosis and hepatocellular carcinoma (HCC). The pathogenesis and pathophysiology of NAFLD are complex and involve different factors (genetic, metabolic, endocrinopathies, and others). One of the concerns that appeared in recent years is hypothyroidism-induced NAFLD. The pathogenesis is compound and not well understood, and an association between hypothyroidism and NAFLD remains controversial because of insufficient studies that can confirm it. More research is needed to determine the association between hypothyroidism and NAFLD and the underlying mechanisms. In this review, we will discuss a more in-depth analysis of the physiology of thyroid hormones (TH) as well as the pathophysiology of hypothyroidism-induced NAFLD and, based on the recent meta-analyses, the association of thyroid hormones and NAFLD.

Keywords: hypothyroidism; hypothyroidism-induced nafld; nonalcoholic fatty liver disease (nafld); thyroid hormones; thyroid-liver axis.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Similar articles

Cited by

References

    1. Norbert Stefan, Hans-Ulrich Häring. The metabolic syndrome at the beginning of the XXI century: a genetic and molecular approach. Madrid: Elsevier España; 2005. Nonalcoholic fatty liver disease: a new entry in the metabolic syndrome? pp. 383–392.
    1. Anna Wieckowska, Ariel E. Feldstein. Pediatric gastrointestinal and liver disease (fourth edition) Saint Louis: W.B. Saunders; 2011. Nonalcoholic fatty liver disease; pp. 804–810.
    1. Association of non-alcoholic fatty liver disease with thyroid function: a systematic review and meta-analysis. Guo Z, Li M, Han B, Qi X. Dig Liver Dis. 2018;50:1153–1162. - PubMed
    1. Hypothyroidism-induced nonalcoholic fatty liver disease (HIN): mechanisms and emerging therapeutic options. Tanase DM, Gosav EM, Neculae E, Costea CF, Ciocoiu M, Hurjui LL. International Journal of Molecular Sciences. 2020;21:5927. - PMC - PubMed
    1. Thyroid hormones, thyromimetics and their metabolites in the treatment of liver disease. Kowalik MA, Columbano A, Perra A. Front Endocrinol (Lausanne) 2018;9:382. - PMC - PubMed

LinkOut - more resources